Line S. Lynggaard
Arhus, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Early prediction of subsequent peg-asparaginase inactivation in acute lymphoblastic leukaemia patients-A NOPHO ALL2008 study.
Journal: British journal of haematology
Published: February 06, 2025
Sequelae and post-thrombotic syndrome after venous thromboembolism in acute lymphoblastic leukemia survivors treated on the NOPHO ALL2008 protocol.
Journal: Pediatric blood & cancer
Published: September 29, 2023
PEG-asparaginase treatment regimens for acute lymphoblastic leukaemia in children: a network meta-analysis.
Journal: The Cochrane database of systematic reviews
Published: June 01, 2023
Asparaginase encapsulated in erythrocytes as second-line treatment in hypersensitive patients with acute lymphoblastic leukaemia.
Journal: British journal of haematology
Published: July 04, 2022
Cerebral sinovenous thrombosis and asparaginase re-exposure in patients aged 1-45 years with acute lymphoblastic leukaemia: A NOPHO ALL2008 study.
Journal: EJHaem
Published: March 28, 2022
Asparaginase encapsulated in erythrocytes as second-line treatment in hypersensitive patients with acute lymphoblastic leukaemia.
Journal: British journal of haematology
Published: January 20, 2022
Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
Journal: The Cochrane database of systematic reviews
Published: October 10, 2020
Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1-3a follicular lymphoma.
Journal: British journal of haematology
Published: May 26, 2017
Last Updated: 09/26/2026